Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Sep 2024 is 16.44% vs 217.39% in Sep 2023
Consolidate Net Profit
YoY Growth in quarter ended Sep 2024 is 26.67% vs -145.02% in Sep 2023
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Sep 2024 is 33.65% vs -5.35% in Sep 2023
Interest
YoY Growth in quarter ended Sep 2024 is -9.52% vs 61.54% in Sep 2023
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Sep 2024 has improved from Sep 2023
Compare Quarterly Results Of Marinus Pharmaceuticals, Inc. With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2024 is 4.94% vs 5.19% in Jun 2024
YoY Growth in quarter ended Sep 2024 is 16.44% vs 217.39% in Sep 2023
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Sep 2024 is 32.40% vs 7.49% in Jun 2024
YoY Growth in quarter ended Sep 2024 is 26.67% vs -145.02% in Sep 2023
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2024 is 30.56% vs 15.69% in Jun 2024
YoY Growth in quarter ended Sep 2024 is 33.65% vs -5.35% in Sep 2023
Quarterly - Interest
QoQ Growth in quarter ended Sep 2024 is -17.39% vs 6.98% in Jun 2024
YoY Growth in quarter ended Sep 2024 is -9.52% vs 61.54% in Sep 2023
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2024 has improved from Jun 2024
YoY Growth in quarter ended Sep 2024 has improved from Sep 2023






